Comparison 14. H2 receptor antagonists versus teprenone.

Outcome or subgroup title	No. of studies	No. of participants	Statistical method	Effect size
1 Clinically important upper GI bleeding	1		Risk Ratio (M‐H, Fixed, 95% CI)	Totals not selected
1.1 Ranitidine vs teprenone	1		Risk Ratio (M‐H, Fixed, 95% CI)	0.0 [0.0, 0.0]
2 All‐cause mortality in ICU	1		Risk Ratio (M‐H, Fixed, 95% CI)	Totals not selected
2.1 Ranitidine vs teprenone	1		Risk Ratio (M‐H, Fixed, 95% CI)	0.0 [0.0, 0.0]
3 Number of participants requiring blood transfusion	1		Risk Ratio (M‐H, Fixed, 95% CI)	Totals not selected
3.1 Ranitidine vs teprenone	1		Risk Ratio (M‐H, Fixed, 95% CI)	0.0 [0.0, 0.0]